News

Why Some People Are Microdosing Popular Weight-Loss Drugs
Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Stocktwits on MSN2d
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull
Shares of telehealth provider Hims & Hers Health Inc. (HIMS) dropped over 3% on Thursday after Cigna Group’s (CI) Evernorth ...
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...
Pensions & Investments5d
Weight-loss drug craze boosts $80 billion Lilly Endowment to largest in U.S.
The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...
What happens to your weight after stopping Ozempic, Wegovy or Mounjaro?
Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...
Health and Me on MSN6d
Why Weight Loss Injections May Work Better for Women?
Recent study show weight loss injections result in greater weight reduction in women than men, with women losing up to 28% of ...